NCT04579588RecruitingAccepts Healthy Volunteers
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Stanford University
Start Date
10/29/2020
Completion Date
4/1/2028
Summary
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Eligibility Criteria
Age Range: 9 years to 64 years
Inclusion Criteria:
* Age 9 through 64 years
* Diagnosed with COVID-19 at least 2 months prior enrollment
* Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
* Patients without COVID-19 diagnosis for controls
Exclusion Criteria:
* Received the influenza vaccine less than 4 months ago
* Pregnant or lactating
* Patients with special risks attendant to venipuncture
* Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment
* Contraindication to the flu vaccine
* Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement
Interventions
BIOLOGICAL
Flu shot
Conditions
Corona Virus InfectionFlu VaccineImmunity
Locations
Stanford University
Palo Alto, California 94304
United States